De Logu, Francesco
Nassini, Romina
Hegron, Alan http://orcid.org/0000-0002-7588-9209
Landini, Lorenzo http://orcid.org/0000-0002-3933-2497
Jensen, Dane D. http://orcid.org/0000-0001-6540-2375
Latorre, Rocco
Ding, Julia
Marini, Matilde http://orcid.org/0000-0002-2199-2905
Souza Monteiro de Araujo, Daniel http://orcid.org/0000-0003-1115-725X
RamÃrez-Garcia, Paulina
Whittaker, Michael
Retamal, Jeffri
Titiz, Mustafa
Innocenti, Alessandro
Davis, Thomas P.
Veldhuis, Nicholas http://orcid.org/0000-0002-8902-9365
Schmidt, Brian L. http://orcid.org/0000-0002-2409-8984
Bunnett, Nigel W. http://orcid.org/0000-0003-3367-0644
Geppetti, Pierangelo http://orcid.org/0000-0003-3797-8371
Article History
Received: 28 July 2021
Accepted: 14 January 2022
First Online: 3 February 2022
Competing interests
: N.W.B. is a founding scientist of Endosome Therapeutics Inc. P.G. is a member of the Scientific Advisory Board of Endosome Therapeutics Inc. The laboratory of N.V. and M.W. has been funded in-part by Endosome Therapeutics Inc. R.N., F.D.L. and P.G. are founding scientists of FloNext Srl. P.G. has been in advisory boards and/or received fees for lectures from Novartis, Amgen, TEVA, AbbVie. The remaining authors declare no competing interests.